The independent source for health policy research, polling, and news.
1,221-1,240 of 113,144 results
Even though Meta and Google are weighing whether to pursue appeals, the findings by two juries indicate public perception of tech companies has shifted, with more people willing to push for changes to protect children's online safety. Minnesota lawmakers have advanced a bill they hope will do just that.
The therapy marketed as Kresladi was initially rejected in 2024 because of manufacturing concerns. It treats leukocyte adhesion deficiency type 1 (LAD-1), an ultra-rare disease — affecting about one in a million — that makes children vulnerable to life-threatening infections and can lead to death.
West Suburban Medical Center in Illinois has been facing difficulties with a new computerized billing system for a year, and that has translated into a lack of revenue to cover normal operating expenses and has led to its temporary closure. Plus: Health care AI company OpenEvidence has just launched a feature to automate the medical coding and billing process.
Conservative House Republicans derided the deal for omitting money for Immigrations and Customs Enforcement and Border Patrol, the two agencies responsible for carrying out President Trump’s immigration crackdown, The New York Times reported.
The Department of Justice has opened inquiries into how race might be considered in the admissions policies at Stanford, Ohio State, and the University of California, San Diego. The department also sued NewYork-Presbyterian and launched an inquiry over trans prisoners in California and Maine.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health topics.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Seven cases are under investigation; all of the people involved were unvaccinated against measles, CBS News reported. The emergency room treatment area of Trinity Health Ann Arbor Hospital in Ypsilanti was potentially exposed to the virus on March 21.
Last month, the FDA rejected a Hunter syndrome gene therapy from Regenxbio over a lack of clinical data. Denali Therapeutics' drug is a form of enzyme replacement therapy — not a gene therapy — that can enter the brain and slow the cognitive decline affecting two-thirds of patients.
The insurers are accused of paying to have customers directed to their Medicare Advantage plans and of paying brokers to limit sign-ups of people with disabilities. The companies deny any wrongdoing.
The company Cord Blood Registry is being sued by the attorneys general of Texas and Arizona over claims about the medical value of storing newborn cord blood, while charging new parents thousands of dollars. The lawsuits ask CBR to remove the false ads and repay families.
Jay Bhattacharya will continue to lead the agency while the administration searches for a permanent director. About six contenders are still under consideration, The Washington Post reports. Also, a month after Casey Means’ confirmation hearings, she still has not secured the surgeon general post.
Jurors ruled that Meta and YouTube were negligent and awarded the plaintiff $6 million in damages. Meanwhile, The New York Times reports on an Irish village making a "phone-free childhood" happen.
Today's early morning highlights from the major news organizations.
During the first year of an Iowa law severely restricting abortion, a 22% drop was observed, according to the Guttmacher Institute. Also: Dietary changes may holistically help manage endometriosis.
A lack of social connections has been linked to higher all-cause death rates. Physical and social isolation were also tied to financial difficulty, including food insecurity and problems paying bills.
Editorial writers examine these public health issues.
The rapidly growing company will spend $2 billion on the suburban Atlanta plant, marking a major expansion into the U.S. Other industry news is on insulin pricing, doctors' drug kickbacks, and more.
Pediatricians are expressing alarm that Haemophilus influenzae type b, or Hib, could be making a return as vaccine hesitancy rises. According to MedPage Today, serious cases are being reported in California, New York, Florida, and elsewhere. Also in the news: measles, alpha-gal syndrome, RSV, and more.
© 2026 KFF